Pfizer Long Term Debt 2012-2026 | PFE

Pfizer long term debt for the quarter ending March 31, 2026 was $57.409B, a 1.02% decline year-over-year.

  • Pfizer long term debt for 2024 was $57.405B, a 6.72% decline from 2023.
  • Pfizer long term debt for 2023 was $61.538B, a 87.14% increase from 2022.
  • Pfizer long term debt for 2022 was $32.884B, a 9.15% decline from 2021.

Pfizer Long Term Debt 2012-2026 | PFE

  • Pfizer long term debt for 2024 was $57.405B, a 6.72% decline from 2023.
  • Pfizer long term debt for 2023 was $61.538B, a 87.14% increase from 2022.
  • Pfizer long term debt for 2022 was $32.884B, a 9.15% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B